CNTB Connect Biopharma Holdings Ltd: institutional ownership and insider trading
56 funds reported holding $33.0M of Connect Biopharma Holdings Ltd in their latest 13F filings; in Q2 2026 funds net bought $2.07M, with 24 new positions and 9 funds selling out; over the last 12 months insiders bought $4.37M and sold $0 on the open market; over its last four quarters it reported revenue of $2.95M and net income of −$69.0M.
CNTB revenue and earnings
- Quarter ended Jun 30, 2026: revenue $2.77M, net income −$17.3M, EPS -0.27
- Quarter ended Mar 31, 2026: revenue $169K, net income −$19.4M, EPS -0.34
- Quarter ended Dec 31, 2025: revenue $0, net income −$15.1M, EPS -0.27
- Quarter ended Sep 30, 2025: revenue $16.0K, net income −$17.2M, EPS -0.31
Famous investors holding CNTB
- Two Sigma (Two Sigma Investments): $475K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $208K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $104K, 0.0% of the portfolio
Largest institutional holders of CNTB
- Ikarian Capital, LLC — $10.8M
- 683 Capital Management, LLC — $3.06M
- BOOTHBAY FUND MANAGEMENT, LLC — $2.32M
- BlackRock, Inc. (BLK) — $2.07M
- PERCEPTIVE ADVISORS LLC — $1.89M
- ADAR1 Capital Management, LLC — $1.67M
- BML Capital Management, LLC — $1.36M
- SILVERARC CAPITAL MANAGEMENT, LLC — $1.30M
- Richmond Brothers, Inc. — $1.27M
- Knott David M Jr — $1.06M
Recent CNTB insider trades
- May 29, 2026: Huang James bought 150,000 shares ($372K)
- Mar 31, 2026: Huang James bought 1,160,000 shares ($4.00M)
5%+ owners
- Panacea Innovation Limited: 21.2% (Schedule 13D/A, filed Apr 1, 2026)
- Braden M Leonard: 6.8% (Schedule 13G, filed Oct 6, 2026)
Who owns the most CNTB stock?
The largest institutional holders of Connect Biopharma Holdings Ltd in the latest 13F filings are Ikarian Capital, LLC ($10.8M), 683 Capital Management, LLC ($3.06M), BOOTHBAY FUND MANAGEMENT, LLC ($2.32M).
Are insiders buying or selling CNTB?
Over the last 12 months insiders bought $4.37M and sold $0 of Connect Biopharma Holdings Ltd stock on the open market (SEC Form 4).
Which famous investors own CNTB?
Two Sigma, Renaissance Technologies, Izzy Englander.
What was CNTB's revenue last quarter?
Connect Biopharma Holdings Ltd reported revenue of $2.77M for the quarter ended June 30, 2026, with net income of −$17.3M.